Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses
Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses
任务C10：肠道病毒和冠状病毒抗病毒药物的化学合成和工艺优化
批准号：
10229674
负责人：
GREG MARTIN
金额：
$84.41万
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-07-31 至 2021-05-30
关键词：
Antiviral AgentsC10ChemistryCommunicable DiseasesCoronavirusDevelopmentDevelopment PlansDrug KineticsEnterovirusEvaluationIn VitroInterventional Agent DevelopmentLeadMicrobiologySafetyServicesSupport ContractsTherapeuticToxicologyToxinchemical synthesisin vivopathogenpre-clinicalprocess optimizationproduct developmentprogramstherapeutic development
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses
-
批准号：10263620
-
项目类别：
-
资助金额：$28.14万
-
财政年份：2020
-
负责人：GREG MARTIN
-
依托单位：
Task C06: Preparation of a non-GMP Antibiotic Candidate
-
批准号：10001659
-
项目类别：
-
资助金额：$78.96万
-
财政年份：2018
-
负责人：GREG MARTIN
-
依托单位：
海外基金
